Aspire Biopharma CEO Interview: Disrupting Drug Delivery with Sublingual Tech
SmallCaps Daily sits down with ASBP’s CEO Kraig Higginson to discuss the company’s disruptive technology and the expected clinical and corporate milestones for 2025.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
